HealthDay

Per-person diabetes-attributable costs ranged from $374 in New Mexico to $1,610 in Washington, D.C.

However, combination is associated with increased risk of major hemorrhage within 90 days

Lucemyra is an oral selective alpha 2-adrenergic receptor agonist

Low screening rate seen at same time as increase in hepatitis C virus prevalence among pregnant women

Patients regard EHR as positive presence; can be used to engage patients by jointly viewing data

Sixty-five percent of cardiologists avoided PCI on two or more occasions due to reporting program concerns

Low rate of evaluation seen in at-risk individuals, but vast majority of those tested are diagnosed with OSA

For episodic migraine patients, reduction in number of migraine days with monthly dosing, single dose

Increase in annual percentage of all visits for suicide ideation, attempts from 2008 to 2015

Reduction in relative amplitude tied to higher risk of lifetime major depressive disorder, bipolar disorder

Risk not increased for non-advanced adenoma found on colonoscopy following flex sigmoidoscopy

Indirect effects for poor prenatal growth, higher postnatal anger on infant reactivity and regulation

Relationship seen with gray matter, white matter, and hippocampal volumes

Nonprofit manufacturer will pursue cost-plus strategy to cover costs, maintain financial viability

Addition of cannabidiol to conventional antiepileptic meds linked to drop in frequency of seizures

Better functional outcomes with alteplase, but small increased rate of intracranial hemorrhage

LN34 is highly accurate and produces results more quickly and cost-effectively than current methods

Reduces probability that screening for rare disease in newborn blood spot test will be recommended